Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,063.89 10.75 (1.02%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 111.38(B)
Last Volume: 518,435 Avg Vol: 759,686
52 Week Range: $692.45 - $1045.37
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 259,662 311,759 469,743
Total Sell Value $188,697,290 $251,749,241 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 45 67 128
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 2430
  Page 23 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sing George L Director   –       •      –    2021-08-13 4 S $620.00 $310,000 D/D (500) 44,563 -0%     
   Sing George L Director   –       •      –    2021-08-12 4 S $611.00 $611,000 D/D (1,000) 45,063 -2%     
   Sing George L Director   –       •      –    2021-08-11 4 S $620.00 $186,000 I/I (300) 3,050 0%     
   Sing George L Director   –       •      –    2021-08-11 4 S $620.00 $1,241,000 D/D (2,000) 46,063 0%     
   Van Plew Daniel P EVP & General Mgr, Industrial   •       –      –    2021-08-10 4 S $606.50 $4,040,105 D/D (6,603) 26,931 -1%     
   Sing George L Director   –       •      –    2021-08-10 4 S $613.01 $1,596,010 D/D (2,600) 48,063 -1%     
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-10 4 AS $611.00 $328,593 D/D (537) 25,903 1%     
   Vagelos P Roy Director   –       •      –    2021-08-09 4 GD $0.00 $0 D/D 17,000 291,090     -
   Van Plew Daniel P EVP & General Mgr, Industrial   •       –      –    2021-08-09 4 D $617.68 $11,363,459 D/D (18,397) 33,534     -
   Van Plew Daniel P EVP & General Mgr, Industrial   •       –      –    2021-08-09 4 OE $270.43 $6,760,750 D/D 25,000 51,931     -
   Brown Michael S Director   –       •      –    2021-08-09 4 S $612.38 $1,033,085 I/I (1,687) 7,662 -3%     
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-09 4 D $617.68 $1,521,346 D/D (2,463) 26,440     -
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-09 4 OE $381.92 $1,145,760 D/D 3,000 28,903     -
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-09 4 AS $610.85 $224,891 D/D (364) 25,903 3%     
   Schleifer Leonard S President & CEO   •       •      –    2021-08-06 4 D $607.51 $138,861,598 D/D (228,575) 504,746     -
   Schleifer Leonard S President & CEO   •       •      –    2021-08-06 4 OE $52.03 $20,812,000 D/D 400,000 596,176     -
   Sing George L Director   –       •      –    2021-08-06 4 S $612.42 $214,347 I/I (350) 3,350 -8%     
   Sing George L Director   –       •      –    2021-08-06 4 S $611.23 $2,445,520 D/D (4,000) 50,663 -8%     
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-06 4 D $607.51 $993,886 D/D (1,636) 26,267     -
   Landry Robert E EVP Finance CFO   •       –      –    2021-08-06 4 OE $381.92 $763,840 D/D 2,000 27,903     -
   Yancopoulos George President and Chief Scientific   •       •      –    2021-08-05 4 AS $600.06 $30,003,000 D/D (50,000) 937,483 11%     
   Bassler Bonnie L Director   –       •      –    2021-08-05 4 AS $600.00 $1,535,400 D/D (2,559) 891 11%     
   Bassler Bonnie L Director   –       •      –    2021-08-05 4 OE $391.92 $1,002,923 D/D 2,559 3,450     -
   Mccourt Marion EVP Commercial   •       –      –    2021-08-02 4 AS $577.12 $577,120 D/D (1,000) 17,038 15%     
   Mccourt Marion EVP Commercial   •       –      –    2021-08-02 4 OE $342.93 $342,930 D/D 1,000 18,038     -
  2430 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 23 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us